HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 336090Generated: October 25, 2026
Hydrochloric Acid → 4-[1-(3-Methylthiophen-2-yl)-meth-(e)-ylidene]-2-(2,4,6-trimethylphenyl)cyclopentane-1,3-dione
https://huagongshe.com/reaction/336090
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | 3-Methyl-2-thiophenecarboxaldehyde | HCID 79911 | — |
| Reactant | 2-(2,4,6-Trimethylphenyl)-3-methoxy-cyclopent-2-enone | HCID 15577646 | — |
| Reactant | Potassium tert-butoxide | HCID 23665647 | — |
| Solvent | Acetone | HCID 180 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | 4-[1-(3-Methylthiophen-2-yl)-meth-(e)-ylidene]-2-(2,4,6-trimethylphenyl)cyclopentane-1,3-dione | HCID 66683884 | 16.9% |
Reaction Steps
Potassium tertiary butoxide (0.53 g, 4.72 mmol) is added to a cold solution of mixture of 3-Methoxy-2-(2,4,6-trimethylphenyl)cyclopent-2-enone (0.5 g, 2.16 mmol) in tetrahydrofuran (5 ml). The reaction mixture is stirred for 30 minutes at 0° C. and to this mixture is added a solution of 3-methyl-2-thiophene carboxaldehyde (0.23 g, 1.82 mmol) in tetrahydrofuran (1 ml). The reaction mixture is stirred at 0° C. for 2 hours, acidified to pH 1 with 2N aqueous hydrochloric acid and the aqueous phase is extracted with ethyl acetate (3×25 ml), the organic phases are combined, washed with water, and dried over anhydrous sodium sulphate. The mixture is filtered, and the filtrate is evaporated under reduced pressure to give a crude residue. The crude residue is dissolved in acetone (6 ml), added concentrated hydrochloric acid (3 ml) and the resulting solution is heated to 60° C. for 8 hrs. The reaction mixture is diluted with water and extracted with ethyl acetate (3×25 ml). The combined organics are washed with brine, dried over sodium sulphate, filtered and concentrated in vacuum to give a residue. This residue is then purified using silica gel column chromatography to give 4-[1-(3-methylthiophen-2-yl)-meth-(E)-ylidene]-2-(2,4,6-trimethylphenyl)cyclopentane-1,3-dione (100 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08889595B2 |
|---|
| Source dataset | uspto-grants-2014_11 |
|---|
| ORD ID | ord-5fdbfc5a5cfe4b9583bf15c44f214310 |
|---|
| Source note | uspto-grants-2014_11 |
|---|